Antiresorptives in patients with chronic kidney disease with adynamic bone: Is absence of evidence of harm equal to no harm?

Kidney Int

Division of Nephrology, Bone and Mineral Metabolism, University of Kentucky, Lexington, Kentucky, USA; Nephrology and Dialysis Unit, Mansoura University, Mansoura, Egypt.

Published: December 2021

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2021.09.011DOI Listing

Publication Analysis

Top Keywords

antiresorptives patients
4
patients chronic
4
chronic kidney
4
kidney disease
4
disease adynamic
4
adynamic bone
4
bone absence
4
absence evidence
4
evidence harm
4
harm equal
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!